Table 1.

Different immunotherapies used for treating ALL and/or CLL.

Target	Drug	Immunotherapy Type	Use and Clinical Indication
CD19	Blinatumomab [39]	BiTE	ALL
	Tisagenlecleucel [40]	CAR	ALL
	Brexucabtagene Autoleucel [40]	CAR	ALL
CD20	Rituximab [33]	Monoclonal Ab	ALL, CLL
	Ofatumumab [34]	Monoclonal Ab	CLL
	Obinutuzumab [35]	Monoclonal Ab	CLL
CD22	Epratuzumab [37]	Monoclonal Ab	ALL (orphan drug)
	Inotuzumab ozogamicin (InO) [38]	Monoclonal Ab	ALL
CD52	Alemtuzumab [41]	Monoclonal Ab	CLL